Andere talen Edwards Lifesciences Corporation Berne S.E.

Aandelen

001065343

US28176E1082

Vertraagde tijd Berne S.E. Andere beurzen 18:00:02 05-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
83,18 ^CHF	+1,86%		-.--%	+20,95%

15:19	Sectorupdate: Gezondheidszorgaandelen maandag stabiel premarket	MT
13:13	Becton, Dickinson neemt Edwards Lifesciences' divisie kritieke zorgproducten over voor $4,2 miljard in contanten	MT

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Sector Update: Health Care Stocks Steady Premarket Monday	15:19
Becton, Dickinson to Acquire Edwards Lifesciences' Critical Care Product Division for $4.2 Billion in Cash	13:13
Edwards Lifesciences to sell critical care products unit to Becton Dickinson for $4.2 bln	12:50
EDWARDS LIFESCIENCES CORPORATION : Citigroup réajuste son opinion à la hausse	22/05
EDWARDS LIFESCIENCES CORPORATION : Deutsche Bank Securities favorable au dossier	14/05
Edwards Lifesciences Insider Sold Shares Worth $439,038, According to a Recent SEC Filing	13/05
Edwards Lifesciences Faces EU Antitrust Complaint By Meril	13/05
Edwards Lifesciences hit with Meril's EU antitrust complaint	13/05
Edwards Lifesciences Corporation Launches the SAPIEN 3 Ultra RESILIA Valve in Europe With Technology to Enhance Durability	09/05
EDWARDS LIFESCIENCES CORPORATION : Barclays toujours neutre sur le dossier	07/05
Edwards Lifesciences Insider Sold Shares Worth $1,212,687, According to a Recent SEC Filing	01/05
Edwards Lifesciences Insider Sold Shares Worth $622,062, According to a Recent SEC Filing	30/04
EDWARDS LIFESCIENCES CORPORATION : Bernstein est neutre	29/04
EDWARDS LIFESCIENCES CORPORATION : Opinion positive de Evercore ISI	26/04
EDWARDS LIFESCIENCES CORPORATION : Stifel Nicolaus conserve son opinion neutre	26/04
EDWARDS LIFESCIENCES CORPORATION : Wells Fargo Securities maintient son opinion neutre	26/04
EDWARDS LIFESCIENCES CORPORATION : UBS toujours neutre sur le dossier	26/04
EDWARDS LIFESCIENCES CORPORATION : Piper Sandler persiste à l'achat	26/04
EDWARDS LIFESCIENCES CORPORATION : Canaccord Genuity persiste à l'achat	26/04
Edwards Lifesciences first-quarter profit beats estimates on heart devices strength	26/04

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Filters

Headlines

Edwards Lifesciences Corporation: het verhaal gaat verder

23 april 2024 om 21:00 uur